The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency
Hanny Al‐Samkari(Harvard University), Rachael F. Grace(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Jennifer Rothman(Duke Medical Center), Alexis A. Thompson(Children's Hospital of Philadelphia), Kathryn Addonizio(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), D. Holmes Morton(Clinic for Special Children), Penelope A. Kosinski(Agios Pharmaceuticals (United States)), Yaddanapudi Ravindranath(The Barbara Ann Karmanos Cancer Institute), Satheesh Chonat(Emory University), Kevin H.M. Kuo(University Health Network), Janet L. Kwiatkowski(Children's Hospital of Philadelphia), Heng Wang(Zhejiang Provincial People's Hospital), Hasan Al‐Sayegh(Sultan Qaboos University), Wendy B. London(Dana-Farber Cancer Institute), Charles Kung(Agios Pharmaceuticals (United States)), Bertil Glader(Stanford University)
Cited by 22
Related Papers
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients
|The American Journal of Human Genetics|2008|417
Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors
|Thrombosis and Haemostasis|1998|355